Skip to main content
. 2017 May 20;10(5):559. doi: 10.3390/ma10050559

Figure 1.

Figure 1

The concept of co-delivery of polyhedral oligomeric silsesquioxane (POSS) and doxorubicin (DOX) into the cell.